Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Accounting systems need an overhaul to better capture modern-day value creation, particularly in the context of climate and ...

The Biden administration’s bird flu response has been too slow. Now comes a test for Trump’s White House.

And regular polling carried out by YouGov suggests adults are increasingly likely to say that vaccines have harmful side ...

A letter from several Democratic Senators urged Trump to use his deal-making skills to “flat out reject any request to end ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

Antibiotics marked the transition to the modern Pfizer. Their follow-up to penicillin ... one of the first in the world to get a COVID-19 vaccine approved – via its collaboration with BioNTech ...

Kennedy, who suspended his independent bid for the presidency to endorse Trump immediately following the Democratic National ...

Alternative energy, however, is where growth potential truly lies. The Inflation Reduction Act of 2022 allocated $369 billion ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...